Movement Alert｜Natera Intraday Decline 4.71%, share resale filing and director stock sale draw attention

Market Focus11-12 23:07

On November 12, Natera fell 4.71% in Regular Trading, trading at $316.405 per share, with turnover of $67.2152 million.

The latest catalyst in focus was a new filing covering the potential resale of up to 68,023 common shares by selling stockholders, alongside a disclosed November 6 sale of 3,150 shares by director and co-founder Jonathan Sheena for about $995,406.

These developments arrived shortly after Natera reported mixed third-quarter results: revenue rose to $794.0 million from $592.2 million and exceeded expectations, while EPS of $(0.42) missed consensus estimates. The company also raised its full-year revenue outlook to $3.005 billion-$3.035 billion. Recent analyst commentary said the company retains a strong growth outlook in minimal residual disease testing, but the near-term share price reaction has remained pressured by the earnings miss and governance-related updates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment